Add BrightSurf on Google Email

Alzheimer’s drug may someday help save lives by inducing a state of “suspended animation”

Researchers successfully put tadpoles into a hibernation-like state using FDA-approved donepezil (DNP), which could be repurposed to save millions of lives every year. The drug induces torpor-like symptoms and can be easily administered, making it a promising tool for emergency situations.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalACS Nano·TypeExperimental study·DateAug 22, 2024

A wearable sensor supported by machine learning models is used to monitor and quantify freezing of gait (FOG) episodes in people with Parkinson's disease

A wearable sensor supported by machine learning models can continuously monitor and quantify FOG episodes, providing an accurate picture of a patient's condition. This technology has the potential to support the development of new treatments and improve the lives of people with Parkinson's disease.

SourceTel-Aviv University·JournalNature Communications·DateAug 18, 2024

Potential new target for early treatment of Alzheimer's disease

A study found that targeting heparan sulfate-modified proteins improves cell repair, rescues neuron loss and reverses cellular changes associated with neurodegenerative diseases. Disrupting these proteins promotes autophagy-dependent cell repair and reverses early cellular problems in models of Alzheimer's.

SourcePenn State·JournaliScience·TypeExperimental study·DateJul 2, 2024

Transforming drug discovery with AI

TopoFormer uses a transformer model trained on tens of thousands of protein-drug interactions to recreate 3D structures as one-dimensional information that current models can understand. This enables more accurate predictions of new drug interactions and potentially reduces development time and costs.

SourceMichigan State University·JournalNature Machine Intelligence·DateJun 21, 2024

New AI tool for rapid and cost-effective drug discovery

PSICHIC uses sequence data and AI to decode protein-molecule interactions with state-of-the-art accuracy, eliminating costly processes like 3D structures. The tool effectively screens new drug candidates and performs selectivity profiling, offering a more efficient and reliable approach to drug discovery.

SourceMonash University·JournalNature Machine Intelligence·TypeData/statistical analysis·DateJun 19, 2024

Insilico Medicine publishes CDK8/19 novel inhibitor powered by generative chemistry platform to treat multiple cancers

Insilico Medicine's lead compound demonstrates strong enzymatic activity, selectivity, and favorable ADME properties, as well as antitumor activity in various animal models. The company's generative AI-powered platform generated over 3,600 candidate molecules before identifying the promising lead compound.

SourceInSilico Medicine·JournalJournal of Medicinal Chemistry·DateMay 14, 2024

How scientists are accelerating chemistry discoveries with automation

A new statistical-modeling workflow can quickly identify molecular structures of products formed by chemical reactions, accelerating drug discovery and synthetic chemistry. The workflow also enables the analysis of unpurified reaction mixtures, reducing time spent on purification and characterization.

SourceDOE/Lawrence Berkeley National Laboratory·JournalJournal of Chemical Information and Modeling·TypeData/statistical analysis·DateApr 8, 2024

Toronto researchers devise new way to find proteins for targeted treatment of disease

Researchers at the University of Toronto and Sinai Health have created a new platform to identify proteins that can be co-opted to control the stability of other proteins. The study identified over 600 new effector proteins that could be used therapeutically, including those that can efficiently degrade or stabilize target proteins.

SourceUniversity of Toronto·JournalNature·TypeExperimental study·DateMar 22, 2024

Fast folding for synthetic peptides and microproteins

Researchers at Xi'an Jiaotong-Liverpool University developed a new method that enables the efficient production of cysteine-rich peptides and microproteins in their naturally folded 3D structure. The approach uses organic solvents to mimic nature's oxidative folding process, resulting in speeds of over 100,000 times faster than aqueous...

SourceXi'an Jiaotong-Liverpool University·JournalAngewandte Chemie·TypeExperimental study·DateMar 21, 2024

Drug candidate may ‘unmask’ latent HIV-infected cells, mark them for destruction

Researchers have identified a potential path to eliminate the viral reservoir that prevents people from being completely cured of HIV. A new drug candidate, called a proteolysis targeting chimeras (PROTAC) molecule, triggers the degradation of the Nef protein, which suppresses HIV replication and restores immune system detection. This ...

SourceUniversity of Pittsburgh·JournalCell Chemical Biology·DateMar 19, 2024

Mimicking exercise with a pill

Researchers have discovered compounds that can activate estrogen-related receptors (ERRs), similar to the effects of exercise on metabolism and muscle growth. The new compounds may offer a substitute for exercise in people with medical conditions, such as heart failure and neurodegenerative disease.

Novel molecules from generative AI to phase II

Researchers used generative AI to design a lead molecule for treating fibrosis, a biological process associated with aging. The compound, INS018_055, demonstrated significant efficacy in preclinical studies and showed promising results in clinical trials, accelerating drug discovery and providing new therapeutic options.

SourceInSilico Medicine·JournalNature Biotechnology·DateMar 11, 2024

Exploring the therapeutic potential of natural mushroom compounds to address psychiatric disorders

A new study suggests that mushroom extract containing psilocybin demonstrates superior efficacy in stimulating neuroplasticity and promoting new connections between nerve cells. The research found that the extract had a more potent and prolonged impact on synaptic plasticity compared to chemically synthesized psilocybin.

SourceThe Hebrew University of Jerusalem·JournalMolecular Psychiatry·TypeExperimental study·DateMar 11, 2024

Can it take just a few minutes to calculate how proteins interact with drugs?

Scientists from IOCB Prague have developed a universal and accurate new computational method to predict how proteins interact with drugs. The SQM2.20 scoring function yields DFT-quality predictions in minutes, significantly accelerating drug discovery.

SourceInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague)·JournalNature Communications·TypeComputational simulation/modeling·DateFeb 20, 2024

Do AI-driven chemistry labs actually work? New metrics promise answers

Researchers at North Carolina State University are developing a suite of performance metrics to standardize the evaluation of self-driving labs in chemistry and materials science. These metrics aim to compare different lab technologies and identify areas for improvement, ultimately advancing the field and accelerating discovery.

SourceNorth Carolina State University·JournalNature Communications·TypeCommentary/editorial·DateFeb 15, 2024

JMC | Insilico Medicine presents the discovery of the potent and selective MYT1 inhibitors for the treatment of cancer through generative AI

Researchers at Insilico Medicine have identified MYT1 as a promising therapeutic target for breast and gynecological cancers. A series of novel, potent, and highly selective inhibitors specifically targeting MYT1 were discovered using AI-driven generative biology and chemistry engine.

SourceInSilico Medicine·JournalJournal of Medicinal Chemistry·DateJan 19, 2024